Phase I Study of Valemetostat and Atezolizumab as Maintenance Therapy for Patients With Extensive-Stage Small Cell Lung Cancer
NCT06807632 · RECRUITING · Phase 1
We track 6 ClinicalTrials.gov studies led by Memorial Sloan Kettering Cancer Center. The portfolio skews toward Phase 2 (4 trials).
6 clinical trials sponsored by Memorial Sloan Kettering Cancer Center.
| Phase | Trials | Distribution |
|---|---|---|
| Phase 2 | 4 | 67% |
| Phase 1 | 2 | 33% |
Memorial Sloan Kettering Cancer Center currently sponsors 6 clinical trials tracked on ReadTheTrial. These span Phase 2, Phase 1.
Memorial Sloan Kettering Cancer Center conducts research across multiple therapeutic areas. Browse the trial listings for details.
Yes, Memorial Sloan Kettering Cancer Center currently has 5 trials that are actively recruiting participants. Check individual trial pages for eligibility criteria and locations.